cloudfront

Report Detail

Pharma & HealthcareGlobal Docetaxel Market Insights, Forecast to 2025

  • RnM2641865
  • |
  • 15 March, 2019
  • |
  • Global
  • |
  • 118 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Docetaxel Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Docetaxel Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Docetaxel Market Size Growth Rate by Product
      • 1.4.2 20 mg/ml
      • 1.4.3 40 mg/ml
      • 1.4.4 60 mg/ml
    • 1.5 Market by End User
      • 1.5.1 Global Docetaxel Market Size Growth Rate by End User
      • 1.5.2 Breast Cancer
      • 1.5.3 Prostate Cancer
      • 1.5.4 Non-small Cell Lung Cancer
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Docetaxel Market Size
      • 2.1.1 Global Docetaxel Revenue 2014-2025
      • 2.1.2 Global Docetaxel Sales 2014-2025
    • 2.2 Docetaxel Growth Rate by Regions
      • 2.2.1 Global Docetaxel Sales by Regions
      • 2.2.2 Global Docetaxel Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Docetaxel Sales by Manufacturers
      • 3.1.1 Docetaxel Sales by Manufacturers
      • 3.1.2 Docetaxel Sales Market Share by Manufacturers
      • 3.1.3 Global Docetaxel Market Concentration Ratio (CR5 and HHI)
    • 3.2 Docetaxel Revenue by Manufacturers
      • 3.2.1 Docetaxel Revenue by Manufacturers (2014-2019)
      • 3.2.2 Docetaxel Revenue Share by Manufacturers (2014-2019)
    • 3.3 Docetaxel Price by Manufacturers
    • 3.4 Docetaxel Manufacturing Base Distribution, Product Types
      • 3.4.1 Docetaxel Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Docetaxel Product Type
      • 3.4.3 Date of International Manufacturers Enter into Docetaxel Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Docetaxel Sales by Product
    • 4.2 Global Docetaxel Revenue by Product
    • 4.3 Docetaxel Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Docetaxel Breakdown Data by End User

    6 North America

    • 6.1 North America Docetaxel by Countries
      • 6.1.1 North America Docetaxel Sales by Countries
      • 6.1.2 North America Docetaxel Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Docetaxel by Product
    • 6.3 North America Docetaxel by End User

    7 Europe

    • 7.1 Europe Docetaxel by Countries
      • 7.1.1 Europe Docetaxel Sales by Countries
      • 7.1.2 Europe Docetaxel Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Docetaxel by Product
    • 7.3 Europe Docetaxel by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Docetaxel by Countries
      • 8.1.1 Asia Pacific Docetaxel Sales by Countries
      • 8.1.2 Asia Pacific Docetaxel Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Docetaxel by Product
    • 8.3 Asia Pacific Docetaxel by End User

    9 Central & South America

    • 9.1 Central & South America Docetaxel by Countries
      • 9.1.1 Central & South America Docetaxel Sales by Countries
      • 9.1.2 Central & South America Docetaxel Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Docetaxel by Product
    • 9.3 Central & South America Docetaxel by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Docetaxel by Countries
      • 10.1.1 Middle East and Africa Docetaxel Sales by Countries
      • 10.1.2 Middle East and Africa Docetaxel Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Docetaxel by Product
    • 10.3 Middle East and Africa Docetaxel by End User

    11 Company Profiles

    • 11.1 Hengrui Medicine
      • 11.1.1 Hengrui Medicine Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Hengrui Medicine Docetaxel Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Hengrui Medicine Docetaxel Products Offered
      • 11.1.5 Hengrui Medicine Recent Development
    • 11.2 Sanofi
      • 11.2.1 Sanofi Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Sanofi Docetaxel Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Sanofi Docetaxel Products Offered
      • 11.2.5 Sanofi Recent Development
    • 11.3 Qilu Pharma
      • 11.3.1 Qilu Pharma Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Qilu Pharma Docetaxel Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Qilu Pharma Docetaxel Products Offered
      • 11.3.5 Qilu Pharma Recent Development
    • 11.4 Shenzhen Main Luck Pharma
      • 11.4.1 Shenzhen Main Luck Pharma Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Shenzhen Main Luck Pharma Docetaxel Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Shenzhen Main Luck Pharma Docetaxel Products Offered
      • 11.4.5 Shenzhen Main Luck Pharma Recent Development
    • 11.5 Jiangsu Aosaikang Pharma
      • 11.5.1 Jiangsu Aosaikang Pharma Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Jiangsu Aosaikang Pharma Docetaxel Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Jiangsu Aosaikang Pharma Docetaxel Products Offered
      • 11.5.5 Jiangsu Aosaikang Pharma Recent Development

    12 Future Forecast

    • 12.1 Docetaxel Market Forecast by Regions
      • 12.1.1 Global Docetaxel Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Docetaxel Revenue Forecast by Regions 2019-2025
    • 12.2 Docetaxel Market Forecast by Product
      • 12.2.1 Global Docetaxel Sales Forecast by Product 2019-2025
      • 12.2.2 Global Docetaxel Revenue Forecast by Product 2019-2025
    • 12.3 Docetaxel Market Forecast by End User
    • 12.4 North America Docetaxel Forecast
    • 12.5 Europe Docetaxel Forecast
    • 12.6 Asia Pacific Docetaxel Forecast
    • 12.7 Central & South America Docetaxel Forecast
    • 12.8 Middle East and Africa Docetaxel Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Docetaxel Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
      The classification of Docetaxel includes 20 mg/ml, 40 mg/ml and 60 mg/ml. And the proportion of 20 mg/ml in 2017 is about 86% and the proportion is stable from 2013 to 2017.
      Docetaxel is widely used For Breast Cancer, Prostate Cancer, Non-small Cell Lung Cancer and Cancer. The most proportion of Docetaxel used for Breast Cancer and the proportion in 2017 is 85%.
      The global Docetaxel market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Docetaxel market based on company, product type, end user and key regions.

      This report studies the global market size of Docetaxel in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Docetaxel in these regions.
      This research report categorizes the global Docetaxel market by top players/brands, region, type and end user. This report also studies the global Docetaxel market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Hengrui Medicine
      Sanofi
      Qilu Pharma
      Shenzhen Main Luck Pharma
      Jiangsu Aosaikang Pharma

      Market size by Product
      20 mg/ml
      40 mg/ml
      60 mg/ml
      Market size by End User
      Breast Cancer
      Prostate Cancer
      Non-small Cell Lung Cancer
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Docetaxel market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Docetaxel market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Docetaxel companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Docetaxel submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Docetaxel are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Docetaxel market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.




      Summary:
      Get latest Market Research Reports on Docetaxel. Industry analysis & Market Report on Docetaxel is a syndicated market report, published as Global Docetaxel Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Docetaxel market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      2,618.85
      3,928.28
      5,237.70
      3,588.78
      5,383.17
      7,177.56
      472,446.00
      708,669.00
      944,892.00
      258,622.26
      387,933.39
      517,244.52
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report